Search Results

Are you interested in learning more about Clinical Diagnostic Laboratories' processes? Read this page to learn more. What to Expect Clinical Diagnostics Laboratories (CDL) will make your specimen collection process safe, quick, and as comfortable as possible. We will also make sure to safeguard your privacy and will be treated with the utmost care and dignity. While walk-ins to our lab are welcome during the week, we highly recommend scheduling an appointment if you are pressed for time or if you will require blood work. Weekends are by appointment only. When Visiting the Lab You Should Bring the Following: If you are paying out of pocket fo r a lab, then a lab request is not necessary to have from your doctor but if you are planning on submitting it to your insurance please bring the lab request from your doctor's office, or ask your doctor to email to us prior to your appointment. Please note that the patient is responsible for verifying if their insurance plan is in-network with our facility as individual insurance policies may have unique requirements that enable a claim to be fully covered. ✔️ A current insurance identification car d, (Medicare, Private Insurance, or HMO/PPO) ✔️A photo Id (Drivers License or employee identification badge) ✔️A health spending card, personal check, cash, or mobile PayPal account. Our Process as a Patient at O ur Facility: View Accepted Insurance 01 Schedule An Appointment 02 On the date and time of your appointment, we'll take your doctor's order and make a copy of your ID and Insurance. We'll also have you sign a consent form during this time 03 Once your information is copied, the proper items for your test will be prepared. This typically takes about 5-10 minutes depending on the test being performed. 04 Meet with the nurse for your test. This process typically takes around 5-10 minutes. 05 Once you finish your test, your results will be delivered to your doctor if you provided an order. If you did not provide an order, the results will be sent as a PDF file to your email address. Results typically take 3-10 days depending on the test perfofrmed. For more information on how long your test might take, please conact us. Schedule An Appointment

Ordering information regarding a Anti-Mitochondrial Antibody (AMA) test for Clinical Diagnostic Laboratories. Mitochondrial M2 Antibody, IgG (ELISA) Ordering Recommendation May be useful in confirming a diagnosis of primary biliary cholangitis. Mnemonic AMA Performed Mon-Sat Methodology Semi-Quantitative Enzyme-Linked Immunosorbent Assay Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Serum separator tube. Specimen Preparation: Separate serum from cells ASAP or within 2 hours of collection. Transfer 0.5 mL to a Standard Transport Tube. (Min: 0.3 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Plasma. Contaminated, hemolyzed, grossly icteric, or severely lipemic specimens. Remarks: Stability: After separation from cells: Ambient: 48 hours; Refrigerated: 2 weeks; Frozen: 1 year (avoid repeated freeze/thaw cycles) Reference Interval 20.0 Units or less Negative 20.1-24.9 Units 25.0 Units or greater Equivocal Positive Interpretive Data Anti-mitochondrial antibodies (AMA) are thought to be present in 90-95% of patients with primary biliary cholangitis (PBC). However, the frequency of detected antibodies may be cohort or assay dependent, as lower sensitivities have been reported. Not all PBC patients are positive for AMA; some patients may be positive for SP100 and/or GP210 antibodies. A negative result does not rule out PBC. Compliance Category: FDA Note CPT Code 86381 Components Component Chart Name Mitochondrial (M2) Antibody, IgG Component Test Code 0050065 LOINC 14251-3 Aliases AMA ANTI-MITOCHONDIRAL ANTIBODY ANTIBODIES TO MICROTUBULE ASSOCIATED PROTEIN 2 ANTIMITOCHONDRIAL ANTIBODIES IMMUNOLOGY PROFILE (AMA) MITOCHONDRIAL ANTIBODIES, SERUM

Ordering information regarding an Ammonia for Clinical Diagnostic Laboratories. Ammonia, Plasma Ordering Recommendation Evaluate status of existing liver disease. Monitor treatment in patients with inborn errors of metabolism. Methodology Enzymatic Assay Performed Mon-Sat Reported Within 24 hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Green (sodium or lithium heparin). Collect on ice. Specimen Preparation: Separate plasma from cells and freeze within 15 minutes of draw time. Specimens need to be spun in a refrigerated centrifuge. Transfer 2 mL plasma to a standard Transport Tube. (Min: 0.25 mL) Storage/Transport Temperature: CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered. Unacceptable Conditions: Serum or blood. Non-frozen specimens. Specimens containing oxalate or citrate Remarks: Stability: After separation from cells: Ambient: Unacceptable; Refrigerated: 2 hours; Frozen: 3 weeks (do not thaw) Reference Interval 0-14 days 95 µmol/L or less 15 days-6 years 68 µmol/L or less Greater than 6 years 72 µmol/L or less Interpretive Data Note CPT Code 82140 Components Component Test Code Component Chart Name LOINC 0020043 Ammonia, Plasma 16362-6 Aliases NH3 Plasma ammonia level

This is the Contact page for Clinical Diagnostic Laboratories. Last Name Email Phone Type your message here... Submit Thanks for submitting! A member of our team will respond to your inquiry as soon as possible. 44355 Premier Plaza, Suite 240 Ashburn, VA 20147

Ordering information regarding Clozapine for Clinical Diagnostic Laboratories. Creatinine, Serum or Plasma Ordering Recommendation Screening test to evaluate kidney function. Methodology Quantitative Enzymatic Assay Performed Mon-Sat Reported Within 24 Hours New York DOH Approval Status This test is New York DOH approved. Specimen Required Patient Preparation: Collect: Plasma separator tube or serum separator tube. Specimen Preparation: Allow serum tube to clot completely at room temperature. Separate serum or plasma from cells within 2 hours of collection. Transfer 1 mL serum or plasma to a standard transport tube. (Min: 0.2 mL) Storage/Transport Temperature: Refrigerated. Unacceptable Conditions: Specimens obtained through catheters used to infuse hyperalimentation fluid. Specimens with potassium oxalate/sodium fluoride, citrate, or EDTA as anticoagulants. Remarks: Stability: After separation from cells: Ambient: 1 week; Refrigerated: 1 week; Frozen: 3 months Reference Interval By Report Interpretive Data Note Assay interference (negative) may be observed when high concentrations of N-acetylcysteine (NAC) are present. Negative interference has also been reported with NAPQI (an acetaminophen metabolite) but only with concentrations at or above those expected during acetaminophen overdose. CPT Code 82565 Components Component Test Code Component Chart Name LOINC 0020025 Creatinine, Serum or Plasma 2160-0 3004293 UH EGFR Aliases Blood Creatinine Serum Creatinine

Ordering information regarding an HPV Self Collection Screen for Clinical Diagnostic Laboratories. HPV Self-Collection Screening (HPV-SCS) Ordering Recommendation The HPV Cervical Cancer Self-Collection Test is a highly sensitive screening tool that enables patients to collect their own vaginal sample using an FDA-approved device. After collection, the specimen is processed using advanced nucleic acid amplification methods (typically PCR-based) to qualitatively detect high-risk HPV DNA associated with cervical cancer. This self-collected approach offers comparable diagnostic accuracy to traditional clinician-collected samples while minimizing discomfort and barriers associated with pelvic examinations, making it an effective option for early detection and timely clinical follow-up. Mnemonic HPV Self-Collection Screening (HPV-SCS) Methodology The specimen is processed using nucleic acid amplification techniques (generally PCR-based methods) to qualitatively detect the presence of high-risk HPV DNA. Performed Mon-Sat Reported Within 3-5 days Specimen Required Patient Preparation: Collect: Wash your hands and remove the sterile self-collection device before gently inserting it into the vagina up to the indicated marker. Rotate the device 2–3 times as instructed to collect an adequate sample, then carefully withdraw it. Refrain from douching, using intravaginal medications, or applying topical agents for at least 48 hours prior to collection. • Avoid sexual intercourse for 24–48 hours before sample collection. • If menstruating, confirm with the provider whether sample collection should be postponed until menses have ceased. Specimen Preparation: Immediately place the collection device into the provided vial containing the appropriate viral transport medium. Secure the vial cap tightly and gently invert the vial to mix the specimen with the medium. Ensure that the specimen is labeled accurately with patient identification and collection date/time. Storage/Transport Temperature: Maintain at 2–8°C during storage and transport. Avoid freezing unless the test kit instructions specifically allow it. Prompt transport to the laboratory is advised to maintain sample integrity. Unacceptable Conditions: Specimens that are unlabeled or improperly labeled. Inadequate sample volume or insufficient cellular material. Contaminated samples (e.g., with menstrual blood or external substances) beyond acceptable limits. Specimens showing leakage or compromised container integrity. Samples exposed to temperatures outside the recommended range prior to processing Remarks: Specimen source required. Stability: Reference Interval Negative Interpretive Data A positive result should be correlated with clinical history and may necessitate additional diagnostic procedures. Careful patient education on follow-up steps and interpretation of results is essential. This test should be used as a screening tool only; abnormal findings must be evaluated in conjunction with other clinical assessments. Note CPT Code 87624 Aliases HPV Cervical Cancer Self-Collection Self-Collected HPV Test HPV DNA Test (Self-Collected) Cervical HPV Self-Sampling

OOPS! There’s Nothing Here...yet. Clinical Diagnostic Laboratories is working hard to make the experience for our physicians and patients as seamless as possible. The page you’re looking for is still under construction. Please come back at a later date or Contact Us if you have any questions. Back to Homepage